Collegium Pharmaceutical Inc (NASDAQ: COLL) is 3.32% higher on its value in year-to-date trading and has touched a low of $23.23 and a high of $42.29 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The COLL stock was last observed hovering at around $29.44 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $29.60, the stock is 0.42% and 4.56% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 0.54% at the moment leaves the stock -6.07% off its SMA200. COLL registered -6.80% loss for a year compared to 6-month loss of -1.63%.
The stock witnessed a -0.77% gain in the last 1 month and extending the period to 3 months gives it a -0.84%, and is -0.30% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.46% over the week and 1.37% over the month.
Collegium Pharmaceutical Inc (COLL) has around 357 employees, a market worth around $951.41M and $664.28M in sales. Current P/E ratio is 24.39 and Fwd P/E is 4.22. Profit margin for the company is 6.61%. Distance from 52-week low is 27.42% and -30.00% from its 52-week high. The company has generated returns on investments over the last 12 months (3.87%).
The EPS is expected to grow by 6.63% this year
The shares outstanding are 32.13M, and float is at 30.79M with Short Float at 15.93%.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.79 million shares valued at $186.55 million. The investor’s holdings represent 17.8626 of the COLL Shares outstanding. As of 2024-06-30, the second largest holder is PACER ADVISORS, INC. with 3.41 million shares valued at $109.75 million to account for 10.5089 of the shares outstanding. The other top investors are EVENTIDE ASSET MANAGEMENT, LLC which holds 2.63 million shares representing 8.1234 and valued at over $84.84 million, while VANGUARD GROUP INC holds 7.3103 of the shares totaling 2.37 million with a market value of $76.34 million.
Collegium Pharmaceutical Inc (COLL) Insider Activity
The most recent transaction is an insider sale by Freund John Gordon, the company’s Director. SEC filings show that Freund John Gordon sold 6,601 shares of the company’s common stock on Jun 09 ’25 at a price of $30.62 per share for a total of $0.2 million. Following the sale, the insider now owns 70658.0 shares.
Still, SEC filings show that on Mar 21 ’25, Tupper Colleen (EVP & Chief Financial Officer) disposed off 6,396 shares at an average price of $30.03 for $0.19 million. The insider now directly holds 156,667 shares of Collegium Pharmaceutical Inc (COLL).
